Our publications related to cancer biomarkers
.
2015.
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160(3):446.
.
2016. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160(3):446.
.
2016. DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017.